Literature DB >> 9768598

A survey of Epi-PEN use in patients with a history of anaphylaxis.

S W Huang1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9768598     DOI: 10.1016/s0091-6749(98)70145-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

1.  Pediatric anaphylaxis management in the prehospital setting.

Authors:  Gunjan Kamdar Tiyyagura; Linda Arnold; David C Cone; Melissa Langhan
Journal:  Prehosp Emerg Care       Date:  2013-09-12       Impact factor: 3.077

2.  Treatment of anaphylaxis: EpiPen, Twinject, or another autoinjector?

Authors:  Alexandre Ackaoui
Journal:  Can Fam Physician       Date:  2011-03       Impact factor: 3.275

Review 3.  Patient Ability to Use Old versus New/Modified Model Adrenaline Autoinjection Emergency Medical Devices for Anaphylaxis in Prehospital Setting: A Systematic Review and Meta-Analysis.

Authors:  Leong Chow Wei; Mohd Boniami Yazid; Mohd Noor Norhayati; Abu Yazid Md Noh; Andey Rahman
Journal:  Healthcare (Basel)       Date:  2022-01-18

4.  Parental food allergy information needs: a qualitative study.

Authors:  Wendy Hu; Carol Grbich; Andrew Kemp
Journal:  Arch Dis Child       Date:  2007-05-08       Impact factor: 3.791

5.  Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement.

Authors:  Sandra M Salter; Richard Loh; Frank M Sanfilippo; Rhonda M Clifford
Journal:  Allergy Asthma Clin Immunol       Date:  2014-09-19       Impact factor: 3.406

Review 6.  Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.

Authors:  Aziz Sheikh; F Estelle R Simons; Victoria Barbour; Allison Worth
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

7.  Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization.

Authors:  Stephen F Kemp; Richard F Lockey; F Estelle R Simons
Journal:  World Allergy Organ J       Date:  2008-07       Impact factor: 4.084

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.